Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Cancer Bioinformatics and Pipeline Development

Michael Lawrence

PhD

🏢Broad Institute of MIT and Harvard🌐USA

Group Leader in Cancer Genomics

55
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Michael Lawrence developed MutSig and MutSigCV, the most widely used statistical methods for identifying significantly mutated cancer driver genes from whole-exome and whole-genome sequencing data, introducing critical corrections for gene-specific mutation rate variation that dramatically reduced false-positive driver gene calls. His work at the Broad Institute has defined the statistical framework for distinguishing driver from passenger mutations in cancer genomes and has been applied across all TCGA cancer types to build the comprehensive catalogue of cancer driver genes. His methods remain the standard for cancer driver gene discovery in large-scale sequencing studies.

Share:

🧪Research Fields 研究领域

MutSig cancer driver analysis
Mutation rate heterogeneity correction
Cancer gene significance testing
Mutational background modeling
Pan-cancer driver discovery

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Michael Lawrence 的研究动态

Follow Michael Lawrence's research updates

留下邮箱,当我们发布与 Michael Lawrence(Broad Institute of MIT and Harvard)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment